Resultados: 6

    ACR Appropriateness Criteria® Pretreatment evaluation and follow-up of invasive cancer of the cervix: 2023 update

    J. Am. Coll. Radiol; 21 (6S), 2024
    Cervical cancer is a common gynecological malignancy worldwide. Cervical cancer is staged based on the International Federation of Gynecology and Obstetrics (FIGO) classification system, which was revised in 2018 to incorporate radiologic and pathologic data. Imaging plays an important role in pretreatme...

    ACR Appropriateness Criteria® Female breast cancer screening: 2023 update

    J. Am. Coll. Radiol; 21 (6S), 2024
    Early detection of breast cancer from regular screening substantially reduces breast cancer mortality and morbidity. Multiple different imaging modalities may be used to screen for breast cancer. Screening recommendations differ based on an individual’s risk of developing breast cancer. Numerous factor...

    Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer

    This guideline covers care for people with a family history of breast, ovarian or another related (prostate or pancreatic) cancer. It aims to improve the long-term health of these families by describing strategies to reduce the risk of and promote early detection of breast cancer (including genetic testi...

    Diretrizes para detecção precoce do câncer de mama no Brasil. II - Novas recomendações nacionais, principais evidências e controvérsias

    Resumo: O câncer de mama é a principal causa de morte por câncer em mulheres no Brasil. As novas diretrizes para detecção precoce no Brasil foram elaboradas com base em revisões sistemáticas da literatura sobre riscos e possíveis benefícios de diversas estratégias de detecção precoce. O objet...

    WHO position paper on mammography screening

    Every year, breast cancer kills more than 500,000 women around the world. In resource-poor settings, a majority of women with breast cancer are diagnosed at an advanced stage of disease; their five-year survival rates are low, ranging from 10-40%. In settings where early detection and basic treatment are...